What is CellOxy Hypermittent Hypoxia


CellOxy IHHT is an innovative approach to treatment that employs controlled exposure to varying oxygen levels to stimulate physiological responses, with applications in medical and wellness contexts. Below is an exploration of this topic, drawing on the available information about CellOxy and the principles of IHHT.


What is CellOxy and IHHT?

CellOxy is a medical device certified for delivering intermittent hypoxic, hyperoxic, or normoxic therapy, known as IHHT. This therapy involves alternating periods of low oxygen (hypoxia) and high oxygen (hyperoxia) exposure, a process that can influence mitochondrial function, metabolic syndrome, and even conditions like Lyme disease. The technology behind CellOxy aims to reprogram cell metabolism, enhance mitochondrial proliferation, and eliminate dysfunctional mitochondria, thereby promoting the health of cells and, by extension, overall well-being.

Pros of CellOxy IHHT

Enhanced Mitochondrial Function

One of the primary benefits of IHHT, as facilitated by CellOxy, is the enhancement of mitochondrial function. By inducing mild stress through hypoxia, the body is encouraged to adapt by improving the efficiency and number of mitochondria, which are critical for energy production in cells.

Versatility in Treatment

The technology offers versatility, being applicable for treating a range of conditions from mitochondrial disorders to metabolic syndromes. Its non-invasive nature and ability to target cellular health broadly make it a versatile tool in both clinical and wellness settings.

Potential for Broad Application

The underlying principles of IHHT suggest potential applications beyond those currently identified, including performance enhancement, accelerated recovery, and even cognitive benefits due to improved cellular health and efficiency.

Cons of CellOxy IHHT

Accessibility and Cost

The technology and therapy are likely to be costly and not widely available, limiting access to those who might benefit from it. Specialized equipment and expertise are required to administer IHHT safely and effectively.

product graphic rev2-01.jpg


CellOxy’s approach to Intermittent Hypoxic-Hyperoxic Therapy represents a fascinating intersection of technology and therapy, with the potential to impact a variety of health conditions positively. Its focus on cellular health and mitochondrial function highlights a foundational approach to wellness that could have far-reaching implications. However, as with any emerging therapy, a balanced view that considers the current limitations in research, accessibility, and potential risks is essential. The ongoing development of IHHT and technologies like CellOxy will likely continue to generate interest and research, potentially expanding its applications and availability in the future.

Scroll to Top